Ginkgo Bioworks brings on Peter Boynton as CCO, John Pierce as advisor
In California, Ginkgo Bioworks has named Peter Boynton its new Chief Commercialization Officer, effective early this summer. The company is seeking to expand into industrial strain improvement, enzymes, and commodity chemicals. To assist with this effort, industry veteran John Pierce has joined as an advisor.
In his new role as Chief Commercialization Officer, Peter Boynton will be responsible for further scaling Ginkgo’s foundry-based approach for delivering organisms to partners. Boynton will also build a sales team and processes to manage key customer relationships across various sectors. Boynton joins Ginkgo from Tate & Lyle, where he most recently was responsible for managing the company’s relationship with a key global account. Previously, Boynton spent four years as Chief Commercial Officer at Amyris, where he led sales and business development in flavors and fragrances. Prior, Boynton was Senior Vice President of bio-products and fermentation at Tate & Lyle, and an executive at Cargill. Boynton has also served on Ginkgo’s Board of Directors for more than two years.
John Pierce joins Ginkgo as an advisor with a wealth of expertise and a detailed understanding of multiple sectors, including commodity chemicals, as well as insight into the various technological approaches involved in the development and commercialization of large-scale fermentation processes. Pierce is currently Chairman of the Board for Global Bioenergies, a company focused on commercialization of renewable hydrocarbons, and previously served as Chief Bioscientist at BP as well as Vice President of Applied Biosciences and Director of Biochemical Sciences and Engineering at DuPont. Pierce will help bolster Ginkgo’s business development and partner relations as the company expands to new market sectors.
Category: Fuels
